SHINEWAY PHARM (02877) Stock Price, News, Quotes-Moomoo

HK Stock MarketDetailed Quotes

02877 SHINEWAY PHARM

Watchlist

9.780
-0.050-0.51%

Market Closed Dec 6 16:08 CST

8.09BMarket Cap6.68P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet
Simply Wall StDec 1 19:09 ET
Hong Kong's Department of Health: To develop Hong Kong into a gateway for the internationalization of traditional Chinese medicine and Chinese herbal medicine.
Secretary for Food and Health of the Hong Kong Special Administrative Region, Dr. Constance Chan, stated that in order to promote the standardization and internationalization of traditional chinese medicine, Hong Kong aims to become a gateway for the internationalization of traditional chinese medicine.
Zhitong FinanceNov 14 01:45 ET
China Shineway Pharmaceutical Group Limited (HKG:2877) Top Key Executive Zhenjiang Li's Holdings Dropped 8.0% in Value as a Result of the Recent Pullback
Simply Wall StNov 13 18:40 ET
shineway pharm (02877) had a turnover of 2.887 billion yuan in the first three quarters, a year-on-year decrease of 16.9%.
Shineway Pharm (02877) announced that as of September 30, 2024, the nine months ended have not been reviewed by auditors...
Zhitong FinanceNov 7 23:12 ET
Express News | China Shineway Pharmaceutical - Nine Months Turnover RMB 2,887 Mln Down 16.9%
ReutersNov 7 23:02 ET
Improved Earnings Required Before China Shineway Pharmaceutical Group Limited (HKG:2877) Stock's 27% Jump Looks Justified
Simply Wall StOct 18 18:14 ET

Comments

Moomoo AI

Mar 16 20:10

Investors are risking future disappointment by paying high for a stock with limited growth expectations. The company's poor earnings outlook isn't affecting its P/E as much as anticipated, suggesting current prices may be unreasonable.

China Shineway Pharmaceutical Group Limited's (HKG:2877) 30% Share Price Surge Not Quite Adding Up

Moomoo AI

Jan 29 17:53

China Shineway Pharmaceutical Group's low P/E ratio may be due to market expectations of limited future growth. Investors accept the low P/E, conceding future earnings probably won't provide any pleasant surprises.

There Is A Reason China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Undemanding

Moomoo AI

Nov 13, 2023 18:00

The raw rate of earnings growth and significant insider holdings indicate a bright future for China Shineway Pharmaceutical Group. These factors make it a company worth keeping on the watchlist for potential investors.

If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity

Helen Swart

Sep 17, 2021 06:07

By looking into Hong Kong Pharma stocks, I have stumbled on $SHINEWAY PHARM (02877.HK)$http://www.aastocks.com/en/stocks/quote/quick-quote.aspx?symbol=02877 and these are the reasons I have bought it:
- the company has no debt
- the current price of a stock is 7.75HKD, while the company had 6.0HKD in cash according to the last financial report: http://api.aconnect.com.hk/Attachment/68080 . As the ex-dividend date passed, the company should have at least 71% of its market cap in cash. Unbelievable.
- in that financial report, the company had a very good first half of 2021.
- over the past 5 years, the company has increased cash values per year and is profitable, even with the current price it trades approximately at its book value, while at this time PE TTM is 13.047.
- the company raised its dividend and made a statement that it plans of increasing the dividends in the future, and the current yield TTM is 9.4%.
Sounds pretty good TBH $Hang Seng Index (800000.HK)$